Table 1 Study design outlining the random allocation of camels into three treatment groups, including the number of animals per group, sex distribution, treatment details, injection sites, and administration technique
Group | Number of Camels | Sex Distribution | Treatment | Injection Sites | Injection Technique |
|---|---|---|---|---|---|
Treatment 1 | 6 (3 males, 3 females) | 3 intact males, 3 non-pregnant females (from each breed) | 100 IU Botulinum Toxin Type A (BOTOX ALLERGAN®) | Upper and lower lips | Multiple sites, 2 cm apart, using a 21-gauge, 5-cm hypodermic needle |
Treatment 2 | 6 (3 males, 3 females) | 3 intact males, 3 non-pregnant females (from each breed) | 200 IU Botulinum Toxin Type A (BOTOX ALLERGAN®) | Upper and lower lips | Multiple sites, 2 cm apart, using a 21-gauge, 5-cm hypodermic needle |
Control (Treatment 3) | 6 (3 males, 3 females) | 3 intact males, 3 non-pregnant females (from each breed) | 5 ml sterile normal saline (0.9% sodium chloride) | Upper and lower lips | Multiple sites, 2 cm apart, using a 21-gauge, 5-cm hypodermic needle |